286 related articles for article (PubMed ID: 24444105)
21. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas.
Ramalingam P; Malpica A; Silva EG; Gershenson DM; Liu JL; Deavers MT
Am J Surg Pathol; 2004 Nov; 28(11):1499-505. PubMed ID: 15489654
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
Pitman MB; Triratanachat S; Young RH; Oliva E
Int J Gynecol Pathol; 2004 Jan; 23(1):58-64. PubMed ID: 14668552
[TBL] [Abstract][Full Text] [Related]
23. SALL4 is a novel diagnostic marker for testicular germ cell tumors.
Cao D; Li J; Guo CC; Allan RW; Humphrey PA
Am J Surg Pathol; 2009 Jul; 33(7):1065-77. PubMed ID: 19390421
[TBL] [Abstract][Full Text] [Related]
24. Ovarian hepatoid yolk sac tumours: morphological, immunohistochemical and ultrastructural features.
Devouassoux-Shisheboran M; Schammel DP; Tavassoli FA
Histopathology; 1999 May; 34(5):462-9. PubMed ID: 10231422
[TBL] [Abstract][Full Text] [Related]
25. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors.
Cao D; Humphrey PA; Allan RW
Cancer; 2009 Jun; 115(12):2640-51. PubMed ID: 19365862
[TBL] [Abstract][Full Text] [Related]
26. Glypican 3 is a sensitive, but not a specific, marker for the diagnosis of yolk sac tumours.
Preda O; Nicolae A; Aneiros-Fernández J; Borda A; Nogales FF
Histopathology; 2011 Jan; 58(2):312-4; author reply 314-5. PubMed ID: 21255065
[No Abstract] [Full Text] [Related]
27. The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumours.
Wruck W; Bremmer F; Kotthoff M; Fichtner A; Skowron MA; Schönberger S; Calaminus G; Vokuhl C; Pfister D; Heidenreich A; Albers P; Adjaye J; Nettersheim D
J Cell Mol Med; 2021 Feb; 25(3):1394-1405. PubMed ID: 33448076
[TBL] [Abstract][Full Text] [Related]
28. Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns.
Zynger DL; McCallum JC; Luan C; Chou PM; Yang XJ
Histopathology; 2010 May; 56(6):750-7. PubMed ID: 20546340
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical differentiation of yolk sac-type alpha-fetoprotein from hepatic-type alpha-fetoprotein.
Okamoto T
Acta Pathol Jpn; 1989 Jan; 39(1):51-4. PubMed ID: 2469293
[TBL] [Abstract][Full Text] [Related]
30. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma.
Cheng L; Zhang S; Talerman A; Roth LM
Hum Pathol; 2010 May; 41(5):716-23. PubMed ID: 20096442
[TBL] [Abstract][Full Text] [Related]
31. Yolk Sac Tumor of the Ovary: A Report of 150 Cases and Review of the Literature.
Young RH; Wong A; Stall JN
Am J Surg Pathol; 2022 Mar; 46(3):309-325. PubMed ID: 34469331
[TBL] [Abstract][Full Text] [Related]
32. Transcription factor GATA-4 is expressed in pediatric yolk sac tumors.
Siltanen S; Anttonen M; Heikkilä P; Narita N; Laitinen M; Ritvos O; Wilson DB; Heikinheimo M
Am J Pathol; 1999 Dec; 155(6):1823-9. PubMed ID: 10595911
[TBL] [Abstract][Full Text] [Related]
33. Krukenberg tumor with yolk sac tumor differentiation.
Zamecnik M; Voltr L; Stuk J; Chlumska A
Int J Gynecol Pathol; 2008 Apr; 27(2):223-8. PubMed ID: 18317220
[TBL] [Abstract][Full Text] [Related]
34. Expression pattern of clinically relevant markers in paediatric germ cell- and sex-cord stromal tumours is similar to adult testicular tumours.
Mosbech CH; Svingen T; Nielsen JE; Toft BG; Rechnitzer C; Petersen BL; Rajpert-De Meyts E; Hoei-Hansen CE
Virchows Arch; 2014 Nov; 465(5):567-77. PubMed ID: 25074678
[TBL] [Abstract][Full Text] [Related]
35. Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells.
Nogales FF; Prat J; Schuldt M; Cruz-Viruel N; Kaur B; D'Angelo E; Matias-Guiu X; Vidal A; McCluggage WG; Oosterhuis JW
Histopathology; 2018 Mar; 72(4):634-647. PubMed ID: 29106744
[TBL] [Abstract][Full Text] [Related]
36. Primary Pediatric Yolk Sac Tumor of Liver With Lung Metastasis: An Unusual Presentation With Diagnosis Aided by LIN28 Immunohistochemistry.
Sekar MD; Pradeep I; Srinivas BH; Toi PC; Govindarajan K; Kayal S
Int J Surg Pathol; 2023 Dec; 31(8):1618-1625. PubMed ID: 37013352
[TBL] [Abstract][Full Text] [Related]
37. ZBTB16 is a sensitive and specific marker in detection of metastatic and extragonadal yolk sac tumour.
Xiao GQ; Priemer DS; Wei C; Aron M; Yang Q; Idrees MT
Histopathology; 2017 Oct; 71(4):562-569. PubMed ID: 28581124
[TBL] [Abstract][Full Text] [Related]
38. Urachal yolk sac tumor penetrating the bladder as a diagnostic challenge: a case report and review of the literature.
Šámal V; Jirásek T; Paldus V; Richter I; Hes O
Diagn Pathol; 2022 Jan; 17(1):8. PubMed ID: 35027045
[TBL] [Abstract][Full Text] [Related]
39. Transcription factor GATA-6 is expressed in malignant endoderm of pediatric yolk sac tumors and in teratomas.
Siltanen S; Heikkilä P; Bielinska M; Wilson DB; Heikinheimo M
Pediatr Res; 2003 Oct; 54(4):542-6. PubMed ID: 12867597
[TBL] [Abstract][Full Text] [Related]
40. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma.
Osada M; Aishima S; Hirahashi M; Takizawa N; Takahashi S; Nakamura K; Tanaka M; Maehara Y; Takayanagi R; Oda Y
Hum Pathol; 2014 Jun; 45(6):1243-50. PubMed ID: 24767858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
